Zobrazeno 1 - 10
of 60
pro vyhledávání: '"BEI-ZHONG LIU"'
Autor:
Lihui Wang, Runda Xu, Daosheng Huang, Pai Peng, Keyong Sun, Jie Hu, Bei-zhong Liu, Liang Fang, Liwen Zhang, Xin Sun, Fei Gu, Ni Tang, Ai-long Huang, Xin Lin, Xun Lan
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-12 (2024)
Abstract Identifying epitopes and their corresponding T-cell receptor (TCR) sequences is crucial in the face of rapidly mutating viruses. Peptide synthesis is often required to confirm the exact epitope sequences, which is time-consuming and expensiv
Externí odkaz:
https://doaj.org/article/aaf1faa28e9d45c0adb8c6cfafefb907
Autor:
Pai Peng, Hai-jun Deng, Jie Hu, Xiao-yu Wei, Jian-jiang Xue, Ting-ting Li, Liang Fang, Bei-zhong Liu, Ai-shun Jin, Feng-li Xu, Kang Wu, Quan-xin Long, Juan Chen, Kai Wang, Ni Tang, Ai-long Huang
Publikováno v:
Cell Discovery, Vol 7, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/9558d3f348be494a8c153e759b508b4f
Autor:
Quan-Xin Long, Yan-Jun Jia, Xin Wang, Hai-Jun Deng, Xiao-Xia Cao, Jun Yuan, Liang Fang, Xu-Rong Cheng, Chao Luo, An-Ran He, Xiao-Jun Tang, Jie-li Hu, Yuan Hu, Ni Tang, Xue-Fei Cai, De-Qiang Wang, Jie Hu, Jing-Fu Qiu, Bei-Zhong Liu, Juan Chen, Ai-long Huang
Publikováno v:
Cell Discovery, Vol 7, Iss 1, Pp 1-14 (2021)
Abstract It is important to evaluate the durability of the protective immune response elicited by primary infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we systematically evaluated the SARS-CoV-2-specific memory B
Externí odkaz:
https://doaj.org/article/fd769fff912442fa8984ecf66ebb6ea9
Autor:
Juan Chen, Zhen-Zhen Zhang, Yao-Kai Chen, Quan-Xin Long, Wen-Guang Tian, Hai-Jun Deng, Jie-Li Hu, Xian-Xiang Zhang, Pu-Liao, Jiang-Lin Xiang, Dao-Xin Wang, Peng Hu, Fa-Chun Zhou, Zhi-Jie Li, Hong-Mei Xu, Xue-Fei Cai, De-Qiang Wang, Yuan Hu, Ni Tang, Bei-Zhong Liu, Gui-Cheng Wu, Ai-Long Huang
Publikováno v:
Genes and Diseases, Vol 7, Iss 4, Pp 535-541 (2020)
In December 2019, the corona virus disease 2019 (COVID-19) caused by novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information on clinical features and immunological profile of COVID-19 in paediatrics. The c
Externí odkaz:
https://doaj.org/article/7dbe460b976e469e8996aa86b5a6a19e
Autor:
Chun-Guang Wang MMed, Liang Zhong MMed, Yong-Li Liu BMed, MMB, Xue-Jun Shi MMed, Long-Qin Shi BN, Li Zeng MMed, Bei-Zhong Liu MD
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
The BCR-ABL kinase inhibitor, imatinib mesylate, is the front-line treatment for chronic myeloid leukemia, but the emergence of imatinib resistance has led to the search for alternative drug treatments. There is a pressing need, therefore, to develop
Externí odkaz:
https://doaj.org/article/c0de4f8ffed14bdeb358923c977e743f
Autor:
Liang Fang, Quanxin Long, Ni Tang, Ailong Huang, Xiao-yu Wei, Pai Peng, Kai Wang, Feng-li Xu, Haijun Deng, Bei-zhong Liu, Jian-jiang Xue, Juan Chen, Aishun Jin, Tingting Li, Jie Hu, Kang Wu
Publikováno v:
Cell Discovery, Vol 7, Iss 1, Pp 1-4 (2021)
Cell Discovery
Cell Discovery
Autor:
Jiang-Lin Xiang, Yao-kai Chen, Guicheng Wu, Dao-Xin Wang, Ailong Huang, Ni Tang, Yuan Hu, Bei-zhong Liu, Juan Chen, Peng Hu, Pu-Liao, Zhenzhen Zhang, Haijun Deng, Quanxin Long, Jieli Hu, Wen-Guang Tian, Xian-Xiang Zhang, Xue-Fei Cai, Hong-Mei Xu, Deqiang Wang, Fachun Zhou, Zhijie Li
Publikováno v:
Genes and Diseases, Vol 7, Iss 4, Pp 535-541 (2020)
Genes & Diseases
Genes & Diseases
In December 2019, the corona virus disease 2019 (COVID-19) caused by novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information on clinical features and immunological profile of COVID-19 in paediatrics. The c
Autor:
Pai Peng, Feng-li Xu, Ni Tang, Feiyang Luo, Ailong Huang, Kang Wu, Kai Wang, Jie Hu, Liang Fang, Jin Xiang, Aishun Jin, Bei-zhong Liu, Xiao-yu Wei
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Spike protein that mediates coronavirus entry into host cells is a major target for COVID-19 vaccines and antibody therapeutics. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03a671ba3ed991e13631297c99e6f189
https://doi.org/10.1101/2021.07.09.451732
https://doi.org/10.1101/2021.07.09.451732
Publikováno v:
Cellular & Molecular Immunology. 19:1440-1440
Autor:
Pai Peng, Ailong Huang, Bei zhong Liu, Liang Fang, Ni Tang, Fei yang Luo, Ai shun Jin, Kai Wang, Jie Hu
Publikováno v:
Cellular and Molecular Immunology
SARS-CoV-2 Spike-specific antibodies contribute the majority of the neutralizing activity in most convalescent human sera. Two SARS-CoV-2 variants, N501Y.V1 (also known as B.1.1.7 lineage or VOC-202012/01) and N501Y.V2 (B.1.351 lineage), reported fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c42103cb9d54130c60dd8c17da8e2f62
https://doi.org/10.1101/2021.01.22.427749
https://doi.org/10.1101/2021.01.22.427749